HAND2 and hepatocellular carcinoma: Although CTD-2510F5.4 and HAND2-AS1 were predicted to modulate and interact with AURKA in HCC based on the integrated analyses, the authors were unable to experimentally validate the expression of these targets in HCC tissues [112].